Showing results (101-110 of 124) with videos related to
Sort By:
Pageof 13
Molecular Therapy. Oncology|May 15, 2024
Oncolytic virus V937 in combination with PD-1 blockade therapy to target immunologically quiescent liver and colorectal cancerThai Q Tran, Jeff Grein, Mohammed Selman, et al.Scientific Reports|April 6, 2017
VLP-based vaccine induces immune control of Staphylococcus aureus virulence regulationSeth M Daly, Jason A Joyner, Kathleen D Triplett, et al.Journal of Virology|December 6, 2013
A vaccine against CCR5 protects a subset of macaques upon intravaginal challenge with simian immunodeficiency virus SIVmac251Koen K A Van Rompay, Zoe Hunter, Kartika Jayashankar, et al.Toxins|July 16, 2020
Vaccination with VLPs Presenting a Linear Neutralizing Domain of <i>S. aureus</i> Hla Elicits Protective ImmunityJason A Joyner, Seth M Daly, Julianne Peabody, et al.The Journal of Infectious Diseases|May 10, 2018
Identification and Immunological Characterization of the Ligand Domain of Plasmodium vivax Reticulocyte Binding Protein 1aFrancis B Ntumngia, Richard Thomson-Luque, Sandra Galusic, et al.Frontiers in Immunology|September 27, 2021
Engineering an Antibody V Gene-Selective VaccineLarance Ronsard, Ashraf S Yousif, Julianne Peabody, et al.NPJ Vaccines|September 28, 2023
A virus-like particle-based bivalent PCSK9 vaccine lowers LDL-cholesterol levels in non-human primatesAlexandra Fowler, Koen K A Van Rompay, Maureen Sampson, et al.Biorxiv : the Preprint Server for Biology|September 11, 2024
A two-dose regimen of Qβ virus-like particle-based vaccines elicit protective antibodies against heroin and fentanylIsabella G Romano, Brandi Johnson-Weaver, Susan B Core, et al.Biorxiv : the Preprint Server for Biology|June 9, 2023
A Virus-like particle-based bivalent PCSK9 vaccine lowers LDL-cholesterol levels in Non-Human PrimatesAlexandra Fowler, Koen K A Van Rompay, Maureen Sampson, et al.Journal for Immunotherapy of Cancer|October 31, 2020
Antitumor efficacy of combined CTLA4/PD-1 blockade without intestinal inflammation is achieved by elimination of FcγR interactionsDavid Bauché, Smita Mauze, Christina Kochel, et al.Pageof 13